Barclays PLC G1 Therapeutics, Inc. Transaction History

Barclays PLC

$327 Billion
Q2 2024

A detailed history of Barclays PLC transactions in G1 Therapeutics, Inc. stock. As of the latest transaction made, Barclays PLC holds 23,032 shares of GTHX stock, worth $164,678. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,032

Previous 6,302 265.47%

Holding current value

$164,678

Previous $27,000 96.3%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.2 - $4.98 $36,806 - $83,315	16,730 Added 265.47%	23,032 $53,000
Q2 2023 Aug 03, 2023	SELL	$2.46 - $3.14 $6,058 - $7,733	-2,463 Reduced 28.1%	6,302 $16,000
Q1 2023 May 04, 2023	SELL	$2.57 - $8.16 $45,514 - $144,513	-17,710 Reduced 66.89%	8,765 $23,000
Q4 2022 Feb 13, 2023	SELL	$5.19 - $13.5 $452,339 - $1.18 Million	-87,156 Reduced 76.7%	26,475 $144,000
Q3 2022 Nov 03, 2022	BUY	$5.17 - $16.99 $587,472 - $1.93 Million	113,631 New	113,631 $1.42 Million
Q2 2022 Aug 12, 2022	SELL	$4.04 - $8.51 $904 - $1,906	-224 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$7.6 - $11.02 $496,196 - $719,484	-65,289 Reduced 99.66%	224 $2,000
Q4 2021 Feb 14, 2022	BUY	$10.16 - $16.17 $495,686 - $788,901	48,788 Added 291.71%	65,513 $669,000
Q3 2021 Nov 09, 2021	BUY	$13.16 - $22.47 $218,824 - $373,631	16,628 Added 17142.27%	16,725 $224,000
Q2 2021 Aug 13, 2021	SELL	$19.57 - $26.32 $4,638 - $6,237	-237 Reduced 70.96%	97 $2,000
Q1 2021 May 13, 2021	SELL	$17.58 - $32.59 $1.61 Million - $2.99 Million	-91,818 Reduced 99.64%	334 $8,000
Q4 2020 Feb 11, 2021	BUY	$10.99 - $20.4 $800,665 - $1.49 Million	72,854 Added 377.52%	92,152 $1.66 Million
Q3 2020 Nov 12, 2020	SELL	$11.55 - $23.75 $53,199 - $109,392	-4,606 Reduced 19.27%	19,298 $222,000
Q2 2020 Aug 12, 2020	BUY	$9.57 - $24.37 $183,188 - $466,490	19,142 Added 401.97%	23,904 $579,000
Q1 2020 May 13, 2020	SELL	$9.07 - $26.32 $345,657 - $1 Million	-38,110 Reduced 88.89%	4,762 $52,000
Q4 2019 Feb 10, 2020	BUY	$20.54 - $31.0 $770,886 - $1.16 Million	37,531 Added 702.7%	42,872 $1.13 Million
Q3 2019 Nov 14, 2019	SELL	$22.78 - $40.58 $464,301 - $827,101	-20,382 Reduced 79.24%	5,341 $122,000
Q2 2019 Aug 14, 2019	BUY	$16.03 - $31.1 $314,220 - $609,622	19,602 Added 320.24%	25,723 $789,000
Q1 2019 May 15, 2019	BUY	$14.4 - $21.45 $47,030 - $70,055	3,266 Added 114.4%	6,121 $101,000
Q4 2018 Feb 14, 2019	SELL	$16.51 - $51.33 $289,172 - $899,044	-17,515 Reduced 85.98%	2,855 $55,000
Q3 2018 Nov 14, 2018	BUY	$43.15 - $67.97 $720,734 - $1.14 Million	16,703 Added 455.49%	20,370 $1.07 Million
Q2 2018 Aug 14, 2018	BUY	$35.06 - $51.17 $11,184 - $16,323	319 Added 9.53%	3,667 $159,000
Q1 2018 May 15, 2018	SELL	$19.05 - $41.76 $13,887 - $30,443	-729 Reduced 17.88%	3,348 $124,000
Q4 2017 Feb 14, 2018	SELL	$19.01 - $26.2 $12,204 - $16,820	-642 Reduced 13.6%	4,077 $81,000
Q3 2017 Nov 14, 2017	BUY	$12.53 - $27.12 $59,129 - $127,979	4,719	4,719 $118,000

Others Institutions Holding GTHX

# of Institutions

Shares Held

3.71M

Call Options Held

11.7K

Put Options Held

View Full List

About G1 Therapeutics, Inc.

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

More about GTHX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account